Alaunos Therapeutics, Inc.
TCRT
Last
$0.79
Day
+0.6%
1y
-80.4%
5y
-99.7%
52w
-83.0%
SPY YTD
+13.3%
XLV
+8.1%
Earnings
2026-11-1334d
EMA 21
1.06
EMA 50
1.41
EMA 200
2.23
20d high
-52.7%
5y high
-99.9%
5y range
0th
Positions held
Your positionsTCRT isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
-24
Hold
avoid
Signal
Strong Sell
Target
$0.97
Stop
$0.63
Stop distance
19.8%
Target vs last
+23.4%
Fundamentals
| Market cap | $2.29M | Enterprise value | $1.86M | Trailing P/E | — | Forward P/E | -1.30 |
| PEG | 0.58 | Price / book | 2.98 | Beta | -0.87 | Dividend yield | 0.00% |
| Revenue growth | — | Earnings growth | — | Gross margin | 0.0% | Operating margin | -1352.3% |
| Profit margin | 0.0% | ROE | -1.9% | ROA | -81.1% | Debt / equity | — |
| Current ratio | 0.77 | Free cash flow | -$1.57M | Analyst recommendation | none | Mean target | — |
| 52w high | $4.50 | 52w low | $0.72 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | — |
| Op margin | — | — | -30233.3% | — | — | — |
| Net income | -$1.0M | -$1.0M | -$0.9M | -$1.2M | -$1.1M | — |
| Gross margin | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — |
| Operating income | -$1.0M | -$1.0M | -$0.9M | -$1.2M | -$1.0M | — |
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $2.9M | — |
| Op margin | -84500.0% | -48120.0% | -569860.0% | -1206.0% | — |
| Net income | -$4.2M | -$4.7M | -$35.1M | -$37.7M | — |
| Gross margin | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | -$4.2M | -$4.8M | -$28.5M | -$35.2M | — |
Headline scan
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
Price (daily)
Full chart · RSI · MACD · patternsTCRT · daily-38.5% over 13 sessions
Close EMA21 EMA50 EMA200
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin